1. Home
  2. PIM vs STXS Comparison

PIM vs STXS Comparison

Compare PIM & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIM
  • STXS
  • Stock Information
  • Founded
  • PIM 1988
  • STXS 1990
  • Country
  • PIM United States
  • STXS United States
  • Employees
  • PIM N/A
  • STXS N/A
  • Industry
  • PIM Finance Companies
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PIM Finance
  • STXS Health Care
  • Exchange
  • PIM Nasdaq
  • STXS Nasdaq
  • Market Cap
  • PIM 160.9M
  • STXS 151.3M
  • IPO Year
  • PIM N/A
  • STXS 2004
  • Fundamental
  • Price
  • PIM $3.32
  • STXS $2.11
  • Analyst Decision
  • PIM
  • STXS
  • Analyst Count
  • PIM 0
  • STXS 0
  • Target Price
  • PIM N/A
  • STXS N/A
  • AVG Volume (30 Days)
  • PIM 57.5K
  • STXS 224.8K
  • Earning Date
  • PIM 01-01-0001
  • STXS 05-12-2025
  • Dividend Yield
  • PIM 8.28%
  • STXS N/A
  • EPS Growth
  • PIM N/A
  • STXS N/A
  • EPS
  • PIM 0.05
  • STXS N/A
  • Revenue
  • PIM N/A
  • STXS $27,510,000.00
  • Revenue This Year
  • PIM N/A
  • STXS $25.90
  • Revenue Next Year
  • PIM N/A
  • STXS $60.57
  • P/E Ratio
  • PIM $63.80
  • STXS N/A
  • Revenue Growth
  • PIM N/A
  • STXS 1.50
  • 52 Week Low
  • PIM $2.90
  • STXS $1.54
  • 52 Week High
  • PIM $3.28
  • STXS $2.72
  • Technical
  • Relative Strength Index (RSI)
  • PIM 52.73
  • STXS 57.13
  • Support Level
  • PIM $3.30
  • STXS $2.07
  • Resistance Level
  • PIM $3.33
  • STXS $2.17
  • Average True Range (ATR)
  • PIM 0.04
  • STXS 0.10
  • MACD
  • PIM 0.00
  • STXS -0.00
  • Stochastic Oscillator
  • PIM 72.73
  • STXS 80.03

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: